BioSpace News Archive

via NewMediaWire – HearAtLast Holdings Inc., a Nevada Corporation, is pleased to announce the long anticipated integration of Crystal Clear Audio, Inc., that HearAtlast acquired in 2019.

Financing led by Blumberg Capital supports Segmed’s mission to aggregate medical data for research in support of improving healthcare around the world

Taiho Oncology, Inc. and Astex Pharmaceuticals, Inc. today announced that data for oral decitabine and cedazuridine (INQOVI® [decitabine and cedazuridine] 35mg/100mg tablets) in intermediate and high-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) will be presented during the 62nd Annual American Society of Hematology Meeting and Exposition (ASH 2020),

Proprio announced that spinal industry veteran Tommy Carls has joined as an advisor to the company.

Patent protects methods of regulating TNF-α to treat cancers, autoimmune disorders, and other disorders associated with chronic inflammation

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX ® in North America , today announced the successful completion of its acquisition by Endo International plc (End

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology based therapies for prevalent inflammatory conditions, announced today that its AP-014 Phase I inhaled Ampion™ clinical study in COVID-19 patients is proceeding to full open enrollment following clearance by the

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that it has successfully completed the nine-months product stability testing that is required by the U.S. Food and Drug Administration (FDA) for its CypCaps™ final product, which will be used in the co

Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it has launched its new Topcon RDx® ocular telehealth software platform to the US market. This press release features multimedia. View the full release here: https:/

MiVu™, a first-ever mucosal integrity (MI) diagnostic system from Diversatek Healthcare, was granted De Novo classification* from the Food and Drug Administration (FDA) for the safety and efficacy in obtaining measurements of electrical properties within esophageal tissue